Haryana Health Minister and BJP Leader Anil Vij, who had volunteered to be the first volunteer in phase three trials for a possible coronavirus vaccine, Covaxin, received a test dose on Friday.
Vij was administered the test dose at Ambala Cantt Civil Hospital, the BJP leader said on Twitter.
Earlier in a tweet, Ani Vij said: “I will be administered a test dose of the coronavirus vaccine #Covaxin, a product of Bharat Biotech, tomorrow at 11am at the Civil Hospital, Ambala Cantt, under the expert supervision of a PGI Rohtak and Health team of physicians. Department. I have volunteered to take the test dose. “
On November 18, Ambala Cantt MLA had said that the third phase of the Covaxin trial would begin in Haryana on November 20 and had volunteered to be the first volunteer to be vaccinated.
“The third phase trial of Covaxin, a Bhart Biotech coronavirus vaccine product, will begin in Haryana on November 20. I volunteered as the first volunteer to get vaccinated,” Haryana Health Minister Anil Vij tweeted.
In Haryana, the Pandit Bhagwat Dayal Sharma University of Health Sciences in Rohtak and the ESIC hospital in Faridabad have been identified among the sites across the country where the trials will take place, according to the statement from Bharat Biotech.
Potential Covid-19 vaccine
Covaxin, a possible Covid-19 vaccine, is being developed indigenously by Bharat Biotech in conjunction with the Indian Council for Medical Research (ICMR).
Vaccine manufacturer Bharat Biotech had previously announced the start of phase 3 trials of the Covid-19 Covaxin vaccine. The Phase 3 trials will involve 26,000 volunteers across India and will be carried out in partnership with ICMR.
Additionally, volunteers who wish to participate in this trial must be adults over 18 years of age.
The company previously said that it has successfully completed the interim analysis of the phase 1 and 2 trials and is working on the phase 3 trials.
This is the largest clinical trial conducted for a Covid-19 vaccine in the country.
.
